ADP-ribosylation factor 6 (ARF6) governs the trafficking of bioactive cargos to tumor-derived microvesicles (TMVs) which comprise a class of extracellular vesicles released from tumor cells that facilitate communication between the tumor and the surrounding microenvironment [57]. The gene discussed is ARF6; the disease is neoplasm.